Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of DermatomyositisGlobeNewsWire • 03/30/21
Corbus Pharmaceuticals (CRBP) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 03/18/21
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/15/21
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial ResultsGlobeNewsWire • 03/15/21
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021GlobeNewsWire • 03/08/21
Corbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 03/04/21
4 Hot Small Cap Stocks: Corbus Pharmaceuticals (NASDAQ: CRBP) Medical Marijuana (OTC US: MJNA) Microvision (NASDAQ: MVIS) and Global Battery Metals (OTC US: REZZF)OTC PR Wire • 02/11/21
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human DiseasesGlobeNewsWire • 01/20/21
Implied Volatility Surging for Corbus Pharmaceuticals (CRBP) Stock OptionsZacks Investment Research • 01/12/21
Are Options Traders Betting on a Big Move in Corbus (CRBP) Stock?Zacks Investment Research • 12/04/20
Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/12/20
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) CEO Yuval Cohen On Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha • 11/10/20
Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/10/20
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate UpdatesGlobeNewsWire • 11/10/20